|
ZMAT2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.642700E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.369400E-04 |
| Normal-vs-Stage2 |
7.281000E-01 |
| Normal-vs-Stage3 |
7.681300E-03 |
| Normal-vs-Stage4 |
2.855600E-03 |
| Stage1-vs-Stage2 |
1.043430E-01 |
| Stage1-vs-Stage3 |
7.823200E-01 |
| Stage1-vs-Stage4 |
5.517800E-01 |
| Stage2-vs-Stage3 |
1.678990E-01 |
| Stage2-vs-Stage4 |
6.814000E-02 |
| Stage3-vs-Stage4 |
4.406000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.776400E-03 |
| Normal-vs-AfricanAmerican |
1.442360E-01 |
| Normal-vs-Asian |
1.068170E-01 |
| Caucasian-vs-AfricanAmerican |
7.350600E-01 |
| Caucasian-vs-Asian |
8.834000E-01 |
| AfricanAmerican-vs-Asian |
8.579000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.980100E-04 |
| Normal-vs-Female |
3.298200E-03 |
| Male-vs-Female |
2.340200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.443900E-03 |
| Normal-vs-Age(41-60Yrs) |
3.459800E-02 |
| Normal-vs-Age(61-80Yrs) |
1.646390E-04 |
| Normal-vs-Age(81-100Yrs) |
3.895700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.666400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.517800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.902200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.740300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.100000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.727200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.856400E-01 |
| Classical-VS-Follicular |
7.005100E-04 |
| Classical-VS-Other |
7.132000E-02 |
| Classical-VS-Normal |
5.507600E-02 |
| Tall-VS-Follicular |
2.222600E-01 |
| Tall-VS-Other |
3.702600E-01 |
| Tall-VS-Normal |
1.434090E-02 |
| Follicular-VS-Other |
5.855000E-01 |
| Follicular-VS-Normal |
6.10540000000048E-05 |
| Other-VS-Normal |
1.034560E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.056300E-03 |
| Normal-vs-N1 |
1.972970E-04 |
| N0-vs-N1 |
5.290100E-02 |
|
|
